A 
Introduction:
Idiopathic hypoparathyroidism presenting in adulthood as refractory status epilepticus is quite rare. 1 We report an underdiagnosed metabolic effect of anti-epileptic therapy leading to the refractory nature of status epilepticus in this case of adult onset idiopathic hypoparathyroidism (IHP) with brain calcinosis syndrome (BCS).
Case report:
A 50 year old post-menopausal female presented to the emergency room with status epilepticus. Intravenous lorazepam was given with no improvement, phenytoin infusion was initiated and she was admitted to the medicine ward. Initial electrolytes reports revealed: normal sodium (140meq/l) ( Enquiry revealed that she had similar attack about a month back & was treated in another hospital. Previous discharge summary mentioned that seizures responded with parenteral diazepam and subsequently a CT scan brain showed multiple hyperdense lesions. On refusal for further stay to that hospital, she was discharged next day with an advice to continue oral phenytoin (300mg/day) therapy.
Despite being on phenytoin, she presented to our hospital with recurrent status epilepticus. Her past, personal and family histories were non-contributory.
After recovery from the status, on clinical examination, she had positive Chvostek and Trousseau sign. Resting tremor and rigidity were present. However, other systemic and fundus examinations did not reveal any abnormality. Routine blood, urine examination and chest x-ray were normal. Blood urea was 28 mg/dl (ref. On endocrine evaluation, related salient biochemical parameters were elucidated (table 1) with biochemical profile of hypocalcemia, hyperphosphatemia and inappropriately low PTH. A final diagnosis of primary hypoparathyroidism was made. Her related family members had normal calcium levels. She had normal free T4 and TSH levels. She also had no evidence of any autoimmune diseases and normal levels of anti TPO antibodies. Subsequently, she was classified as having idiopathic primary hypoparathyroidism.
Parameters Value
Calcium (mg/dl) (8. Oral calcium was initiated with a dose of 2g/day in divided doses and calcitriol of 0.5 μg/day. Phenytoin was stopped and lamotrigine was chosen as oral antiepileptic after a discussion with neurologist. With this approach, even after 10 months, she remains seizure free till last follow up. Serum calcium is being maintained at low-normal levels and serum phosphorus had normalized with a normal 24 hour urinary calcium excretion.
Discussion:
Hypoparathyroidism (HP) can be of varied etiology. 1 Hypoparathyroidism for long-standing duration can lead to brain calcinosis syndrome (BCS) which is defined as bilateral calcium accumulation in the brain parenchyma, most often within the basal ganglia. 2 Clinically, basal ganglia calcification may have diverse presentations including mental deterioration, disorders of cerebellar or extra-pyramidal function, movement disorders, chorea and parkinsonian features. 2 Primary hypoparathyroidism presenting as refractory status epilepticus in adulthood is rare. 1 This case of primary hypoparathyroidism, at 50 years of age, presented for the first time without any history of hypocalcemic symptoms earlier. Subsequently, she was diagnosed as isolated idiopathic hypoparathyroidism (IHP) and brain calcinosis syndrome. The patient also developed refractory status epilepticus despite on anti-epileptic therapy (phenytoin).
When status epilepticus (SE) is refractory to first and second line anticonvulsants, the condition becomes critical 5 For treatment of these patients, non-enzyme-inducing anticonvulsants are preferred. So far the knowledge goes; lamotrigine does not have any effect on calcium and bone dynamics. 6 Despite the evidence suggesting adverse effects of different anti-epileptics including valproic acid on bone & calcium metabolism, there appears to be a lack of awareness among medical fraternity about these possible metabolic effects.
Also, in presence of hypoparathyroidism, phenytoin therapy could be potentially epileptogenic, by aggravating hypocalcemia, as in our case. So for the prevention of these potentially preventable effects, choosing the right anti-epileptic would be crucial in patients with seizure disorders secondary to abnormalities in calcium metabolism.
